BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/24/2022 2:13:21 PM | Browse: 366 | Download: 623
 |
Received |
|
2021-10-12 14:45 |
|
Peer-Review Started |
|
2021-10-12 14:47 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-02 07:49 |
|
Revised |
|
2021-12-15 20:43 |
|
Second Decision |
|
2022-02-11 05:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-02-13 16:52 |
|
Articles in Press |
|
2022-02-13 16:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-08 01:23 |
|
Publish the Manuscript Online |
|
2022-03-24 14:13 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatitis E in immunocompromised individuals
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Konstantinos Damiris, Mohamad Aghaie Meybodi, Mumtaz Niazi and Nikolaos Pyrsopoulos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos Damiris, Consultant, MS, Doctor, Doctor, Department of Medicine, Rutgers - New Jersey Medical School, 150 Bergen Street, Newark, New Jersey 07103, United States. kd705@njms.rutgers.edu |
| Key Words |
Hepatitis E; Hepatitis E virus; Chronic hepatitis; Acute hepatitis; Immunocompromised; Liver transplant |
| Core Tip |
Hepatitis E Virus is a leading cause of acute icteric hepatitis in developing countries. Despite being self- limiting in most cases, immunocompromised individuals are at a risk of chronic hepatitis, which can be life threatening. Hallmark of treatment includes reduction of immunosuppressive therapies followed by possible need of anti-viral therapy, which has shown to be ineffective. |
| Publish Date |
2022-03-24 14:13 |
| Citation |
Damiris K, Aghaie Meybodi M, Niazi M, Pyrsopoulos N. Hepatitis E in immunocompromised individuals. World J Hepatol 2022; 14(3): 482-494 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i3/482.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i3.482 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
